RADL3 logo

Raia Drogasil S.A. Stock Price

BOVESPA:RADL3 Community·R$32.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author
Create a narrative

RADL3 Share Price Performance

R$18.83
-6.55 (-25.81%)
34.0% undervalued intrinsic discount
R$28.54
Fair Value
R$18.83
-6.55 (-25.81%)
39.3% undervalued intrinsic discount
R$31.00
Fair Value
Price R$18.83
AnalystHighTarget R$31.00
AnalystConsensusTarget R$21.58
AnalystLowTarget R$14.50

RADL3 Community Narratives

AnalystHighTarget·Updated
Fair Value R$28.54 34.0% undervalued intrinsic discount

Digital Momentum And Demographic Shifts Will Drive Retail Health Expansion

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value R$21.58 12.7% undervalued intrinsic discount

Brazil Aging Trends And Digital Channels Will Elevate Retail Performance

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AnalystLowTarget·Updated
Fair Value R$14.5 29.9% overvalued intrinsic discount

Accelerating E-Commerce Shift And Rapid Expansion Will Compress Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent RADL3 News & Updates

The Return Trends At Raia Drogasil (BVMF:RADL3) Look Promising

Sep 14
The Return Trends At Raia Drogasil (BVMF:RADL3) Look Promising

Here's Why Raia Drogasil (BVMF:RADL3) Can Manage Its Debt Responsibly

Aug 27
Here's Why Raia Drogasil (BVMF:RADL3) Can Manage Its Debt Responsibly

Earnings Not Telling The Story For Raia Drogasil S.A. (BVMF:RADL3) After Shares Rise 27%

Aug 09
Earnings Not Telling The Story For Raia Drogasil S.A. (BVMF:RADL3) After Shares Rise 27%

Results: Raia Drogasil S.A. Beat Earnings Expectations And Analysts Now Have New Forecasts

Aug 08
Results: Raia Drogasil S.A. Beat Earnings Expectations And Analysts Now Have New Forecasts

Raia Drogasil S.A. Key Details

R$41.0b

Revenue

R$28.9b

Cost of Revenue

R$12.0b

Gross Profit

R$10.8b

Other Expenses

R$1.2b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.71
Gross Margin
29.40%
Net Profit Margin
2.98%
Debt/Equity Ratio
55.3%

Raia Drogasil S.A. Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Solid track record with reasonable growth potential.

2 Risks
2 Rewards
View Full Analysis

About RADL3

Founded
1905
Employees
67114
CEO
Renato Raduan
WebsiteView website
rdsaude.com.br

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, Pernambuco, Paraná, Rio de Janeiro and Bahia. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Market Insight

Header cover image

✨Rare Earths: Tiny Market, Outsized Influence

Richard Bowman avatarRichard Bowman
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Last Week
⚡ Utilities: Defensive Dividends Meet the AI Power Surge

⚡ Utilities: Defensive Dividends Meet the AI Power Surge

Brazilian Market Performance

  • 7 Days: -1.5%
  • 3 Months: -0.9%
  • 1 Year: 0.2%
  • Year to Date: 12.8%
Over the past 7 days, the market has dropped 1.5% with the Financials sector contributing the most to the decline. Although the market performance has been flat over the past year. Looking forward, earnings are forecast to grow by 12% annually. Market details ›